Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.

MLA

Liu, Zhaoqiang, et al. “Design, Synthesis and Anti-HIV Evaluation of Novel Diarylpyridine Derivatives as Potent HIV-1 NNRTIs.” European Journal of Medicinal Chemistry, vol. 140, Nov. 2017, pp. 383–91. EBSCOhost, https://doi.org/10.1016/j.ejmech.2017.07.012.

APA

Liu, Z., Tian, Y., Liu, J., Huang, B., Kang, D., De Clercq, E., Daelemans, D., Pannecouque, C., Zhan, P., & Liu, X. (2017). Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs. European Journal of Medicinal Chemistry, 140, 383–391. https://doi.org/10.1016/j.ejmech.2017.07.012

Chicago

Liu, Zhaoqiang, Ye Tian, Jinghan Liu, Boshi Huang, Dongwei Kang, Erik De Clercq, Dirk Daelemans, Christophe Pannecouque, Peng Zhan, and Xinyong Liu. 2017. “Design, Synthesis and Anti-HIV Evaluation of Novel Diarylpyridine Derivatives as Potent HIV-1 NNRTIs.” European Journal of Medicinal Chemistry 140 (November): 383–91. doi:10.1016/j.ejmech.2017.07.012.